Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
esophageal cancer
gastric cancer
meat intake
processed meat
red meat
risk factor
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
revised:
25
03
2022
received:
13
01
2022
accepted:
29
03
2022
pubmed:
1
5
2022
medline:
13
8
2022
entrez:
30
4
2022
Statut:
ppublish
Résumé
Red meat and processed meat are associated with some gastrointestinal cancers. Our study aims to investigate the association of different meat types with esophageal and gastric cancer (EC, GC) in a high-risk population. The Golestan Cohort Study (GCS) is a population-based cohort of 50 045 individuals aged 40 to 75 from northeast Iran. Detailed data on different exposures were collected using validated questionnaires. We considered quintiles of meat consumption, using grams and density (g/1000 kcal/day). We calculated intake of red, processed, organ and white meat, as well as total red meat, including the first three. We used proportional hazards regression models to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for the association between meat types and cancer. During 12 years of follow-up, out of 49 585 participants (57.4% women), 369 developed EC (48.2% women) and 368 developed GC (27.5% women), including 309 esophageal squamous cell, 20 esophageal adenocarcinomas, 216 cardia and 95 non-cardia GC. No association was found for EC except for red meat among females (HR for one quintile increase 1.13, 95% CI = 1.00-1.27). The risk of GC increased for intake of total red meat (HR 1.08, 95% CI = 1.00-1.17) and red meat separately (HR 1.09, 95% CI = 1.00-1.18). The HR for red meat and non-cardia GC was 1.23 (95% CI = 1.02-1.48). No associations were observed for other types of meat. In conclusion, in this high-risk population red meat intake is associated with GC, but not EC, suggesting a substantial role of this modifiable factor in determining the burden of GC.
Identifiants
pubmed: 35489023
doi: 10.1002/ijc.34056
pmc: PMC9543688
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1005-1012Subventions
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Références
Eur J Clin Nutr. 2006 Aug;60(8):971-7
pubmed: 16465196
Cancer Med. 2019 Oct;8(13):6114-6126
pubmed: 31448582
J Epidemiol Community Health. 2001 Jul;55(7):508-14
pubmed: 11413183
Ann Intern Med. 2019 Nov 19;171(10):711-720
pubmed: 31569214
J Acad Nutr Diet. 2019 Jul;119(7):1085-1098.e12
pubmed: 31234969
Cancer Res. 2015 Nov 15;75(22):4876-83
pubmed: 26383162
Arch Iran Med. 2020 Jun 01;23(6):362-368
pubmed: 32536172
BMJ. 2017 May 9;357:j1957
pubmed: 28487287
Int J Cancer. 2005 Jan 20;113(3):456-63
pubmed: 15455378
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Osong Public Health Res Perspect. 2015 Apr;6(2):100-5
pubmed: 25938019
Int J Cancer. 2020 Jul 1;147(1):45-55
pubmed: 31584199
PLoS One. 2013 Aug 14;8(8):e70955
pubmed: 23967140
Dig Dis Sci. 2014 Mar;59(3):664-73
pubmed: 24395380
Eur J Gastroenterol Hepatol. 2000 Dec;12(12):1263-5
pubmed: 11192313
PLoS One. 2010 Jun 17;5(6):e11183
pubmed: 20567597
Nat Rev Dis Primers. 2017 Jul 27;3:17048
pubmed: 28748917
Nutrients. 2019 Apr 11;11(4):
pubmed: 30979076
Gut. 2015 Dec;64(12):1881-8
pubmed: 25748648
Med J Islam Repub Iran. 2021 Apr 13;35:48
pubmed: 34268236
J Natl Cancer Inst. 2006 Mar 1;98(5):345-54
pubmed: 16507831
Arch Iran Med. 2013 Jun;16(6):320-3
pubmed: 23725063
Nutr Cancer. 2014;66(4):550-7
pubmed: 24666234
Am J Gastroenterol. 2021 Aug 1;116(8):1667-1675
pubmed: 33767101
Middle East J Dig Dis. 2016 Oct;8(4):249-266
pubmed: 27957288
Lancet Glob Health. 2020 May;8(5):e649-e660
pubmed: 32353313
Eur J Cancer Prev. 2019 Sep;28(5):397-412
pubmed: 31386635
Int J Epidemiol. 2010 Feb;39(1):52-9
pubmed: 19332502
Int J Cancer. 2022 Oct 1;151(7):1005-1012
pubmed: 35489023
Ann Oncol. 2012 Sep;23(9):2319-2326
pubmed: 22351741
Cancer Epidemiol. 2020 Aug;67:101728
pubmed: 32554298